SRF617
Showing 1 - 5 of 5
Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)
Active, not recruiting
- Advanced Solid Tumor
- SRF617
- +3 more
-
Duarte, California
- +9 more
Nov 28, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in San Antonio (SRF114)
Recruiting
- Advanced Solid Tumor
- Head and Neck Squamous Cell Carcinoma
-
San Antonio, TexasSTART- San Antonio
Jan 2, 2023
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Subjects Diagnosed With Neovascular-AMD
Recruiting
- Retinal Neovascularization
-
Boston, Massachusetts
- +2 more
Dec 6, 2022